Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: current evidence

Treatments for hepatitis C virus (HCV) have advanced greatly, becoming more efficacious with fewer adverse events, due to the availability of direct-acting antiviral agents, which target specific steps in the HCV life cycle. Recently, a combination regimen consisting of the HCV nonstructural protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Morikawa, Kenichi, Nakamura, Akihisa, Shimazaki, Tomoe, Sakamoto, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132225/
https://www.ncbi.nlm.nih.gov/pubmed/30233138
http://dx.doi.org/10.2147/DDDT.S133697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132225/
https://www.ncbi.nlm.nih.gov/pubmed/30233138
http://dx.doi.org/10.2147/DDDT.S133697

Ejemplares similares